Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162

NCT01348555 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT01348555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01348555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162
Lead sponsor
Pierre Fabre Medicament
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2011
Completion date
July 31, 2012
Enrollment
108 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease